FTRE vs VERA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
FTRE · Fortrea Holdings$18.55 ▼ 7.94%
VERA · Vera Therapeutics$25.45 ▼ 4.86%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- FTRE +55.2%
- VERA -13.0%
Head to head
| Metric | FTRE | VERA |
|---|---|---|
| Price | $18.55 | $25.45 |
| Change today | ▼ 7.94% | ▼ 4.86% |
| Market cap | $1.79B | $1.84B |
| Return, 3 months | +1.3% | -24.5% |
| Return, year to date | +7.5% | -49.7% |
| Return, 1 year | +70.2% | -10.6% |
| P/E (TTM) | – | – |
| P/B | 3.4 | 5.5 |
| P/E percentile vs own 5y | 14th | 78th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -1.4% | – |
| Net profit growth (YoY) | +103.8% | -16.7% |
| Gross margin | 20.0% | 67.9% |
| Operating margin | 1.7% | -4,160.1% |
| Net margin | -2.6% | -4,041.2% |
| Return on equity | -12.3% | -113.5% |
| Analyst target vs. price | +35.5% | +175.8% |
| Analyst buy share | 64% | 83% |
| RSI (14) | 37 | 36 |
| 30-day volatility | 70.0% | 62.4% |
| Max drawdown, 1 year | -51.8% | -54.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VERA is the largest of the group by market value.
- FTRE has returned the most over the past year.
- FTRE keeps the most profit per dollar of sales.
- VERA has been the calmest stock over the last 30 days.